171 related articles for article (PubMed ID: 37832905)
1. The pentraxin family in autoimmune disease.
Li Y; Zhang S; Liu J; Zhang Y; Zhang N; Cheng Q; Zhang H; Wu X
Clin Chim Acta; 2023 Nov; 551():117592. PubMed ID: 37832905
[TBL] [Abstract][Full Text] [Related]
2. Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology.
Oggioni M; Mercurio D; Minuta D; Fumagalli S; Popiolek-Barczyk K; Sironi M; Ciechanowska A; Ippati S; De Blasio D; Perego C; Mika J; Garlanda C; De Simoni MG
Sci Rep; 2021 May; 11(1):9616. PubMed ID: 33953334
[TBL] [Abstract][Full Text] [Related]
3. The yin-yang of long pentraxin PTX3 in inflammation and immunity.
Daigo K; Mantovani A; Bottazzi B
Immunol Lett; 2014 Sep; 161(1):38-43. PubMed ID: 24792672
[TBL] [Abstract][Full Text] [Related]
4. Pattern recognition by pentraxins.
Agrawal A; Singh PP; Bottazzi B; Garlanda C; Mantovani A
Adv Exp Med Biol; 2009; 653():98-116. PubMed ID: 19799114
[TBL] [Abstract][Full Text] [Related]
5. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
6. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling.
Bottazzi B; Inforzato A; Messa M; Barbagallo M; Magrini E; Garlanda C; Mantovani A
J Hepatol; 2016 Jun; 64(6):1416-27. PubMed ID: 26921689
[TBL] [Abstract][Full Text] [Related]
7. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.
Bottazzi B; Vouret-Craviari V; Bastone A; De Gioia L; Matteucci C; Peri G; Spreafico F; Pausa M; D'Ettorre C; Gianazza E; Tagliabue A; Salmona M; Tedesco F; Introna M; Mantovani A
J Biol Chem; 1997 Dec; 272(52):32817-23. PubMed ID: 9407058
[TBL] [Abstract][Full Text] [Related]
8. The long pentraxin PTX3 promotes fibrocyte differentiation.
Pilling D; Cox N; Vakil V; Verbeek JS; Gomer RH
PLoS One; 2015; 10(3):e0119709. PubMed ID: 25774777
[TBL] [Abstract][Full Text] [Related]
9. Pentraxins and atherosclerosis: the role of PTX3.
Garlanda C; Bottazzi B; Moalli F; Deban L; Molla F; Latini R; Mantovani A
Curr Pharm Des; 2011; 17(1):38-46. PubMed ID: 21226667
[TBL] [Abstract][Full Text] [Related]
10. Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
Brilland B; Vinatier E; Subra JF; Jeannin P; Augusto JF; Delneste Y
Front Immunol; 2020; 11():626343. PubMed ID: 33664737
[TBL] [Abstract][Full Text] [Related]
11. Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3.
Lech M; Rommele C; Anders HJ
Nephrol Dial Transplant; 2013 Apr; 28(4):803-11. PubMed ID: 23243042
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past.
Qiu C; Han Y; Zhang H; Liu T; Hou H; Luo D; Yu M; Bian K; Zhao Y; Xiao X
Int J Med Sci; 2021; 18(8):1886-1898. PubMed ID: 33746606
[TBL] [Abstract][Full Text] [Related]
13. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.
Garlanda C; Hirsch E; Bozza S; Salustri A; De Acetis M; Nota R; Maccagno A; Riva F; Bottazzi B; Peri G; Doni A; Vago L; Botto M; De Santis R; Carminati P; Siracusa G; Altruda F; Vecchi A; Romani L; Mantovani A
Nature; 2002 Nov; 420(6912):182-6. PubMed ID: 12432394
[TBL] [Abstract][Full Text] [Related]
14. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
Norata GD; Garlanda C; Catapano AL
Trends Cardiovasc Med; 2010 Feb; 20(2):35-40. PubMed ID: 20656213
[TBL] [Abstract][Full Text] [Related]
15. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
Mantovani A; Garlanda C; Doni A; Bottazzi B
J Clin Immunol; 2008 Jan; 28(1):1-13. PubMed ID: 17828584
[TBL] [Abstract][Full Text] [Related]
16. Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.
Augusto JF; Poli C; Beauvillain C; Subra JF; Jaillon S; Renier G; Chevailler A; Puéchal X; Delneste Y; Jeannin P
Int Rev Immunol; 2017 May; 36(3):145-153. PubMed ID: 28471269
[TBL] [Abstract][Full Text] [Related]
17. Pentraxin 3: A promising therapeutic target for autoimmune diseases.
Wu Q; Cao F; Tao J; Li X; Zheng SG; Pan HF
Autoimmun Rev; 2020 Dec; 19(12):102584. PubMed ID: 32534154
[TBL] [Abstract][Full Text] [Related]
18. Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation.
Deban L; Bottazzi B; Garlanda C; de la Torre YM; Mantovani A
Biofactors; 2009; 35(2):138-45. PubMed ID: 19449441
[TBL] [Abstract][Full Text] [Related]
19. Pentraxins in invertebrates and vertebrates: From structure, function and evolution to clinical applications.
Wang Y; Chen W; Ding S; Wang W; Wang C
Dev Comp Immunol; 2023 Dec; 149():105064. PubMed ID: 37734429
[TBL] [Abstract][Full Text] [Related]
20. The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?
Magrini E; Mantovani A; Garlanda C
Trends Mol Med; 2016 Jun; 22(6):497-510. PubMed ID: 27179743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
